drugset / Trial / NCT01933763
An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193
RandomizedSingle-groupQuadruple-blindTreatment
Summary
Study to assess the safety and tolerability of ascending single-doses of REGN1193 in healthy volunteers.
Timeline
- Start
- 2013-08
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CROTEDUMAB | Monoclonal antibody | — | — |
Indications
No indication recorded.